CN105106217B - A kind of maternal nutritional replenishers and preparation method thereof - Google Patents
A kind of maternal nutritional replenishers and preparation method thereof Download PDFInfo
- Publication number
- CN105106217B CN105106217B CN201510496987.5A CN201510496987A CN105106217B CN 105106217 B CN105106217 B CN 105106217B CN 201510496987 A CN201510496987 A CN 201510496987A CN 105106217 B CN105106217 B CN 105106217B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- parts
- metafolin
- maternal nutritional
- folic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 47
- 230000008774 maternal effect Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- ZNOVTXRBGFNYRX-STQMWFEESA-N (6S)-5-methyltetrahydrofolic acid Chemical compound C([C@@H]1N(C=2C(=O)N=C(N)NC=2NC1)C)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-STQMWFEESA-N 0.000 claims description 42
- 229960003208 levomefolic acid Drugs 0.000 claims description 35
- 239000011782 vitamin Substances 0.000 claims description 25
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 17
- 229930003231 vitamin Natural products 0.000 claims description 17
- 235000013343 vitamin Nutrition 0.000 claims description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 17
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 239000000395 magnesium oxide Substances 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 7
- 239000011790 ferrous sulphate Substances 0.000 claims description 7
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 7
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 7
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract description 62
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract description 31
- 235000019152 folic acid Nutrition 0.000 abstract description 31
- 239000011724 folic acid Substances 0.000 abstract description 31
- 229960000304 folic acid Drugs 0.000 abstract description 31
- 239000004475 Arginine Substances 0.000 abstract description 27
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 27
- 229930003779 Vitamin B12 Natural products 0.000 abstract description 20
- 235000019163 vitamin B12 Nutrition 0.000 abstract description 20
- 239000011715 vitamin B12 Substances 0.000 abstract description 20
- 210000003754 fetus Anatomy 0.000 abstract description 14
- 238000001727 in vivo Methods 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 238000001179 sorption measurement Methods 0.000 abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 abstract description 4
- FBOZXECLQNJBKD-UHFFFAOYSA-N methotrexate Chemical class C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-UHFFFAOYSA-N 0.000 abstract description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 25
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 19
- 230000000694 effects Effects 0.000 description 14
- 230000035935 pregnancy Effects 0.000 description 13
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 13
- 229940011671 vitamin b6 Drugs 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 11
- 235000019158 vitamin B6 Nutrition 0.000 description 11
- 239000011726 vitamin B6 Substances 0.000 description 11
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 239000013589 supplement Substances 0.000 description 8
- 229960003495 thiamine Drugs 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 7
- 229930003451 Vitamin B1 Natural products 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229960003512 nicotinic acid Drugs 0.000 description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 7
- 235000010374 vitamin B1 Nutrition 0.000 description 7
- 239000011691 vitamin B1 Substances 0.000 description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 6
- 229930003537 Vitamin B3 Natural products 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 229940083466 soybean lecithin Drugs 0.000 description 6
- 235000019160 vitamin B3 Nutrition 0.000 description 6
- 239000011708 vitamin B3 Substances 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 101001116314 Homo sapiens Methionine synthase reductase Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 2
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- ZFLASALABLFSNM-QBOHGLHMSA-L carbanide;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-oc Chemical compound [CH3-].[Co+3].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ZFLASALABLFSNM-QBOHGLHMSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000002296 eclampsia Diseases 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229960005321 mecobalamin Drugs 0.000 description 2
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 2
- 235000007672 methylcobalamin Nutrition 0.000 description 2
- 239000011585 methylcobalamin Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102100024614 Methionine synthase reductase Human genes 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000009233 Morning Sickness Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000034850 Vomiting in pregnancy Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000011325 biochemical measurement Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940076136 ferrous iodide Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 description 1
- 239000011578 levomefolic acid Substances 0.000 description 1
- 235000007635 levomefolic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- -1 metafolin Calcium salt Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019191 thiamine mononitrate Nutrition 0.000 description 1
- 239000011748 thiamine mononitrate Substances 0.000 description 1
- 229960004860 thiamine mononitrate Drugs 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 208000002670 vitamin B12 deficiency Diseases 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 150000003772 α-tocopherols Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of maternal nutritional replenishers, including following components：L methopterins or L methopterin salt, the maternal nutritional replenishers further include that following two components are made：Arginine and vitamin B12.The preparation method of above-mentioned maternal nutritional replenishers：All components are uniformly mixed.Beneficial effects of the present invention are：The invention replaces folic acid in maternal nutritional supplement field with L methopterins, avoids the problem of folic acid is unable to sorption enhanced caused by gene defect, and avoid the adverse reaction of the accumulation of folic acid in vivo when being unable to sorption enhanced folic acid.Addition arginine is combined with L methopterins and vitamin B12, is played a protective role to pregnant woman and fetus, and some of pregnant women's and embryo growth and development frequently-occurring diseases is avoided to occur.
Description
Technical field
The invention belongs to field of health care products, and in particular to a kind of maternal nutritional replenishers and preparation method thereof.
Background technology
Gestation or intended pregnancy women are the special populations for being different from population.They ensure the pregnant institute that secures good health
The all nutrients of need, simultaneously as in view of the presence of foetus, the supplement of nutrient is paid particular attention to safely, soon
It is fast and effective.Wherein one kind most well-known in folic acid maternal nutritional element the most, is valued by people.
But in the metabolism of human body, folic acid, which is transformed into after methopterin, just has physiological function.And some are due to base
The defect of cause cannot complete dependent conversion process in vivo, still, special pass of the pregnant or intended pregnancy women due to constitution
System can not do related gene detection in period of gestation or plan period of gestation, this may cause to supplement folic acid still not
It can get a desired effect.
In addition, the ingredient of maternal nutritional replenishers is single at present, the effect of extra-nutrition is limited, cannot be satisfied people increasingly
The needs to health increased.
Invention content
In order to solve the above problem of the existing technology, the present invention provides a kind of maternal nutritional replenishers and its preparations
Method.The maternal nutritional replenishers replace traditional folic acid using methopterin, improve absorption problem, meanwhile, the pregnant woman
Ingredient in nutritional supplement is various, the significant effect of extra-nutrition.
The technical solution adopted in the present invention is：A kind of maternal nutritional replenishers, including following components：Metafolin or
Metafolin salt, the maternal nutritional replenishers further include that following two components are made：Arginine and vitamin B12.
Preferably, the maternal nutritional replenishers further include following components：Magnesia and vitamin B6.
Preferably, the maternal nutritional replenishers further include following components：Vitamin B1, vitamin B2, vitamin B3, dimension
Raw element C, vitamine D3, vitamin E, calcium carbonate, ferrous sulfate, iodide and soybean lecithin.
Further, the maternal nutritional replenishers include the component of following mass parts：1-2 parts of metafolin or 1-
2 parts of metafolin salt, the maternal nutritional replenishers further include that the component of following mass parts is made：20-600 parts of smart ammonia
Acid and 0.5-1.5 parts of vitamin B12.
Further, the maternal nutritional replenishers include the component of following mass parts：1-2 parts of metafolin or 1-
2 parts of metafolin salt, the maternal nutritional replenishers further include that the component of following mass parts is made：20-600 parts of smart ammonia
Acid, 0.5-1.5 parts of vitamin B12,30-100 parts of magnesia and 5-45 parts of vitamin B6.
Further, the maternal nutritional replenishers include the component of following mass parts：1-2 parts of metafolin or 1-
2 parts of metafolin salt, the maternal nutritional replenishers further include that the component of following mass parts is made：20-600 parts of smart ammonia
Acid, 0.5-1.5 parts of vitamin B12,30-100 parts of magnesia, 5-45 parts of vitamin B6,1-2 parts of vitamin B1,1-2
The vitamin B2 of part, 15-20 parts of vitamin B3,70-100 parts of vitamin C, 1-10 parts of vitamine D3,5-25 parts of dimension
E, 60-160 parts of calcium carbonate of raw element, 5-50 parts of ferrous sulfate, 180-260 parts of iodide and 200-500 parts of soybean ovum
Phosphatide.
Preferably, the metafolin salt is metafolin calcium or metafolin magnesium.As metafolin
Calcium salt and magnesium salts, while supplementing metafolin, also supplement calcium constituent and magnesium elements, in addition, metafolin at
After salt, chemical property is also more stablized.
The preparation method of above-mentioned maternal nutritional replenishers：All components are uniformly mixed.
For beneficial effects of the present invention are explained further, now each component of the present invention is further elaborated：
The existence form of metafolin or metafolin salt in vivo is the same, that is to say, that the two is in nutrition
Play the role of being identical in replenishers, in order to describe conveniently, the present invention is unified to use metafolin when narration acts on
To express.
Metafolin is also known as (6s) -5-methyltetrahydrofolate, is the form that is primarily present of activity in man's folic acid, folic acid
Being transformed into after methopterin just has physiological function.Folic acid will can be just converted by internal physiological metabolism step with biology
Active metafolin, metafolin can be by blood-brain barrier, cross-film conveying, and then plays physiological function.
But during folic acid is converted to metafolin, the ginseng of methylenetetrahydrofolate reductase and MTRR enzymes is needed
With cooperation, methylenetetrahydrofolate reductase and MTRR enzymes are controlled by two genes of mthfr gene and MTRR respectively, and in people
In group, the occupation rate population of missing or the above-mentioned at least one gene of defect is about 18%, and local district occurred frequently is up to 40%
Crowd cannot be effectively converted to bioactivity using folic acid up to 70% in specific crowd (such as depression)
Metafolin, it is significant to note that, in pregnant woman depression crowd about 70%, so, in pregnant woman group, have
Sizable ratio cannot convert folic acid to metafolin, since whether pregnant woman seldom goes the body for understanding them that can
Folic acid is enough absorbed and converts, a big chunk Supplement of folic acid actually in them is invalid, it might therefore and cause them
The shortage of itself and fetus actually metafolin.
And for this specific group of pregnant woman, in gestation, blood circulation is more vigorous, to metafolin
Demand is also apparently higher than common people.So in pregnant woman's often a large amount of Supplement of folic acid in gestation, but when it in vivo cannot
When effective conversion, two serious consequences can be caused：It 1, cannot since folic acid cannot be converted into the metafolin of physiological action
The folic acid residual of conversion can damage pregnant woman and fetus；2, the presence of internal folic acid can cover the table of vitamin B12 deficiency
Existing symptom, that is to say, that when folic acid cannot be by timely sorption enhanced, even if being deficient in vitamin B12 simultaneously in vivo, pregnant woman oneself
Not only itself can not discover, and general chemical examination inspection can not also detect.And lacking folic acid and vitamin B12 all may cause such as
The corresponding illness such as pregnant woman anemia occurs, and if the two all lacks, the incidence probability of corresponding illness will be significantly greatly increased, these pregnant woman
Corresponding illness can greatly harm embryo growth and development.
After furtheing investigate the above-mentioned mechanism of action, inventor is creative directly to be made using metafolin instead of conventional
Folic acid, the present invention can directly supplement the metafolin for having bioactivity needed for body, and which greatly enhances this
The scope of application and effective percentage of invention.
Arginine is the semi-dispensable amino acid of common people, is essential amino acid for fetus, infant, is to safeguard nerve
Bioactive substance necessary to system and blood circulation normal function.Arginine is the direct precursor for synthesizing NO (nitric oxide),
It is the main matter for maintaining and ensureing endothelial cell normal work, can improves, promote blood circulation.Research shows that increasing arginine
Supply not only helps increase NO and generates and protect, improves inner skin cell function；And help to increase the work of NO synzyme
Property.
Arginine is human body semi-dispensable amino acid, and pregnant woman, due to physiological particularity, researches on arginine requirement is more than common people
More, pregnant woman, which has heredity, age and illness factor, can all lead to the shortage of arginine in vivo.Gravid woman is at this time with greater need for benefit
Sufficient enough arginine, not only meet itself needs, since fetus can only obtain arginine from parent, more to meet fetal growth
The needs of development.In addition, supplement arginine Human Umbilical Vein Endothelial Cells shield, pregnant woman's blood vessel elasticity can be kept, promotes blood
Cycle prevents the hypertension of pregnancy and eclampsia breaking-out.
For fetus, arginine is essential amino acid, indispensable enhancing development nutriment.Arginine
Have and promote growth hormone release action, studies have shown that arginine can prevent the too small disease of fetus, promote its increase height, weight,
Intellectual development makes fetus items physical signs reach health standards.From this point of view, it is very necessary in pregnancy period supplement arginine
's.
Vitamin B12 is called cobalamin, is the unique vitamin containing metallic element.In the present invention, the life of vitamin B12
Reason effect mainly has：1, as the co-factor of transmethylase, the synthesis of methionine, thymidine etc. is participated in；2, L- first is protected
The transfer and storage of base folic acid in the cell.
The function of magnesia：Magnesium is the necessary composition of a variety of enzymes, and enzyme in the manufacture of protein, fat metabolism and is lost
It passes duplication of matter DNA etc. and plays very important effect in the process；On the other hand, magnesium or internal help are absorbed and are utilized
Calcareous poising agent can promote absorption of the cell to calcium, while enhance immune system.Currently, domestic, there are unilateral simple
The problem of the extra-nutrition unevenness of " whole people replenish the calcium ", therefore lead to the shortage of calcium uptake auxiliary agent magnesium.Magnesia in the present invention, one
Aspect can with the activity of enzyme in reinforcement, on the other hand may also help in absorb it is calcareous, reach the health indicator of calcium balance.
Vitamin B6 is also known as pyridoxine comprising pyridoxol, pyridoxal and pyridoxamine are deposited in the form of phosphate in vivo
It is being a kind of water soluble vitamin, is meeting light or alkali destructible, non-refractory.Vitamin B6 acts predominantly on the blood of human body, flesh
These positions of meat, nerve, skin；The physiological reaction being primarily involved in has the manufacturing of hydrochloric acid in gastric juice in the synthesis of antibody, digestive system, fat
With protein utilization and maintenance sodium/potassium balance.
Vitamin B1 is also known as thiamine, is white crystal；Vitamin B1 physiological function is to improve a poor appetite, and is maintaining nerve just
Often activity.Vitamin B2 is also known as riboflavin, is slightly soluble in water, and heating is stable in neutral or acid solution.Vitamin B2
Major physiological functions is to promote to be metabolized as coenzyme.Vitamin B3 is also known as niacin, is a kind of water soluble vitamin, promotes Digestive
The health of system mitigates gastrointestinal disorders；Keep skin healthier；Prevent the gentle serious migraine of solution；It promotes blood circulation, makes blood pressure
Decline.
Pregnant women lacks B family vitamin, it may appear that tired, weak, small legs and tachycardia symptom；Also will appear
Matter and energy metabolic disorder, is easy to happen hypoferric anemia, this will all reduce absorption of the parent to nutrition, cause fetus each side
Flour nutrition lacks, and easily influences the development of brain, causes fetus phrenoblabia, easily cries and screams after birth, is uneasy, is irritated, while will also draw
Gastrointestinal peristalsis decrease, constipation, digestive juice secretion reduction, the symptoms such as loss of appetite are played, and accelerate the morning sickness of pregnant woman, are made
Parent is worse to the absorption of nutrition, causes fetus various aspects nutritional deficiency, to severely impact the development of brain, influences fetus the present
Intelligence afterwards, therefore pregnant woman is centainly it is noted that the intake of B family vitamin.
Vitamin C is also known as L-AA, and in human body, vitamin C is high-efficiency antioxidant agent, for mitigating ascorbic acid
The oxidation stress of peroxidase substrate, in addition, participating in making there are many more vitamin C is also required in important biosynthetic process
With.
Vitamine D3 is a kind of liposoluble vitamin, is also regarded as a kind of hormone precursor acting on Ca,P metabolism, dimension
Raw element D3 may participate in the metabolism of calcium and phosphorus, promote its absorption, and play an important role to New bone formation.Vitamin E is a kind of liposoluble
Property vitamin, hydrolysate be tocopherol, be one of most important antioxidant.
Calcium carbonate is a kind of inorganic compound, in the present invention, mainly as calcium constituent replenishers.Ferrous sulfate is a kind of
Inorganic compound, in the present invention, mainly as ferro element replenishers.Iodide in the present invention, are mended mainly as iodine
Fill agent.Soybean lecithin (Lecithin Himgh Potency) is also known as Lecithin High Potency, and soybean lecithin is the group of cell membrane
At part, enhancing cellular informatics transmission capacity improves brain activity, promotes cell membrane self-repairing capability and protects liver, resists outer
Portion encroaches on ability.
Beneficial effects of the present invention are：
1, the invention in maternal nutritional supplement field replaces folic acid with metafolin, and it is scarce to avoid Yin Jiyin
The problem of folic acid caused by falling into is unable to sorption enhanced, and avoid the accumulation of folic acid in vivo when being unable to sorption enhanced folic acid
Adverse reaction.
2, arginine is added in the maternal nutritional replenishers in the present invention, arginine is the half required amino of common people
Acid, but be essential amino acid for fetus, infant, arginine can promote blood circulation, and pregnant women's is made to meet blood
Liquid overactive circulation needs, and effectively meets the needs of the more semi-dispensable amino acids of pregnant woman's period of gestation, while meeting tire
Youngster's essential amino acid needs；Avoid pregnant woman such as anaemia, the hypertension of pregnancy and eclampsia, pregnant depression these pregnant woman's common diseases hair
It is raw；Most importantly two kinds of substances of metafolin and arginine, which combine, has amalgamation good, without physiology side reaction residue
Matter, pregnant woman fetus are free from side effects while obtaining protection and maximum nutritional supplementation benefit.
3, the maternal nutritional replenishers ingredient in the present invention is various, and the nutrition for enumerating pregnant woman substantially in gestational period whole is mended
Agent can reach a kind of tonic, the effect of multi-efficiency.
Specific implementation mode
With reference to specific embodiment, the present invention is further elaborated.
Embodiment 1
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin of 1mg, the arginine of 20mg and
The vitamin B12 of 0.5mg.
Embodiment 2
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin calcium of 2mg, the arginine of 600mg
With the vitamin B12 of 1.5mg.
Embodiment 3
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin magnesium of 1.5mg, the smart ammonia of 310mg
The vitamin B12 of acid and 1mg.
Embodiment 4
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin calcium of 1mg, the arginine of 20mg
With the vitamin B12 of 0.5mg, the vitamin B6 of the magnesia of 30mg and 5mg.
Embodiment 5
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin magnesium of 2mg, the arginine of 600mg
With the vitamin B12 of 1.5mg, the vitamin B6 of the magnesia of 100mg and 45mg.
Embodiment 6
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin of 1.5mg, the arginine of 310mg
With the vitamin B12 of 1mg, the vitamin B6 of the magnesia of 65mg and 25mg.
Embodiment 7
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin magnesium of 1mg, the arginine of 20mg
With the vitamin B12 of 0.5mg, the magnesia of 30mg, the vitamin B6 of 5mg, the vitamin B1 of 1mg, 1mg vitamin B2,
The vitamin B3 of 15mg, the vitamin C of 70mg, the vitamine D3 of 1mg, 5mg parts of vitamin E, the calcium carbonate of 60mg, 5mg
The soybean lecithin of ferrous sulfate, the iodide of 180mg and 200mg.
Embodiment 8
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin of 2mg, the arginine of 600mg and
The vitamin B12 of 1.5mg, the magnesia of 100mg, the vitamin B6 of 45mg, the vitamin B1 of 2mg, 2mg vitamin B2,
The vitamin B3 of 20mg, the vitamin C of 100mg, the vitamine D3 of 10mg, 25mg parts of vitamin E, 160mg calcium carbonate,
The soybean lecithin of the ferrous sulfate of 50mg, the iodide of 260mg and 500mg.
Embodiment 9
A kind of maternal nutritional replenishers, include the component of following quality：The metafolin calcium of 1.5mg, the smart ammonia of 310mg
The vitamin of acid and the vitamin B12 of 1mg, the magnesia of 65mg, the vitamin B6 of 25mg, the vitamin B1 of 1.5mg, 1.5mg
The vitamin B3 of B2,17mg, the vitamin C of 85mg, the vitamine D3 of 5mg, 15mg parts of vitamin E, 110mg calcium carbonate,
The soybean lecithin of the ferrous sulfate of 30mg, the iodide of 220mg and 350mg.
The preparation method of any maternal nutritional replenishers of embodiment 1-9：All components are uniformly mixed.It needs
Illustrate, in above-described embodiment, vitamin B12 is in the form of Mecobalamin；Vitamine D3 is in the form of d- alpha-tocopherols；Vitamin B1
In the form of thiamine mononitrate；Vitamin B3 is in the form of niacinamide；For vitamin B6 in the form of pyridoxime 5-phosphate, above-mentioned form has life
The advantages of object activity is high, good absorption effect.Mecobalamin is a kind of biologically active form of vitamin B12.Methyl-B12 is dimension life
The principal mode of vitamin B12 in the cycle of plain B12, therefore be also to be primarily present form into peripheral tissues.Methyl-B12
It is absorbed by using the specific enteron aisle mechanism such as internal factor and diffusion mode, absorptivity is high
To prove the validity of the maternal nutritional replenishers, following clinical test has been done：
300 pregnant woman are chosen in this experiment, are randomly divided into one group of experiment, test two groups and control group, every group of 100 people, and three
Age, physical condition between group and the bad border no difference of science of statistics of life.
Since the first month that is pregnant, one group of experiment daily maternal nutritional replenishers in embodiment 2 test two groups
The daily maternal nutritional replenishers in embodiment 8, control group daily commercially available folic acid.Three groups are continuously taken to life
Production.Wherein, it tests one group and two groups of experiment is respectively taken once daily morning and evening, be the dosage described in embodiment every time, control
Group is normally taken according to the specification of commercially available folic acid.
3rd month, the 6th month and September periodically carry out biochemical measurement to all pregnant woman, and statistical data see the table below 1.
Table 1：The sick situation contrast table of every group of pregnant woman
It will be obvious from table 1, the pregnant woman of one group of experiment is significantly better than control group, institute in the physiological status of period of gestation
The with obvious effects better than common commercially available folic acid of maternal nutritional replenishers provided by the invention is stated, in addition, the pregnant woman of two groups of experiment exists
The physiological status of period of gestation, which is slightly better than, tests one group, illustrates that the dietary supplement of two groups of experiment is more comprehensive, resultant effect
More preferably.
The present invention is not limited to above-mentioned preferred forms, anyone can show that other are various under the inspiration of the present invention
The product of form, however, make any variation in its shape or structure, it is every that there is skill identical or similar to the present application
Art scheme, is within the scope of the present invention.
Claims (3)
1. a kind of maternal nutritional replenishers, which is characterized in that include the component of following mass parts：1-2 parts of metafolin or
1-2 parts of metafolin salt, the maternal nutritional replenishers further include the component of following mass parts：20-600 parts of smart ammonia
Acid, 0.5-1.5 parts of vitamin B12,30-100 parts of magnesia, 5-45 parts of vitamin B6,1-2 parts of vitamin B1,1-2
The vitamin B2 of part, 15-20 parts of vitamin B3,70-100 parts of vitamin C, 1-10 parts of vitamine D3,5-25 parts of dimension
E, 60-160 parts of calcium carbonate of raw element, 5-50 parts of ferrous sulfate, 180-260 parts of iodide and 200-500 parts of soybean ovum
Phosphatide.
2. maternal nutritional replenishers according to claim 1, which is characterized in that the metafolin salt is L- methyl leaves
Sour calcium or metafolin magnesium.
3. the preparation method of maternal nutritional replenishers described in claim 1, which is characterized in that be uniformly mixed all components i.e.
It can.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510496987.5A CN105106217B (en) | 2015-08-13 | 2015-08-13 | A kind of maternal nutritional replenishers and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510496987.5A CN105106217B (en) | 2015-08-13 | 2015-08-13 | A kind of maternal nutritional replenishers and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105106217A CN105106217A (en) | 2015-12-02 |
| CN105106217B true CN105106217B (en) | 2018-08-28 |
Family
ID=54654500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510496987.5A Active CN105106217B (en) | 2015-08-13 | 2015-08-13 | A kind of maternal nutritional replenishers and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105106217B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109170904A (en) * | 2018-08-30 | 2019-01-11 | 山西康惠中天医药科技有限公司 | A kind of maternal nutritional replenishers and preparation method thereof |
| CN110269255A (en) * | 2019-05-28 | 2019-09-24 | 山东医可康医药科技有限公司 | A kind of fruits and vegetables Active folic acid reducing homocysteine |
| CN111374310A (en) * | 2020-04-16 | 2020-07-07 | 上海益跬尔生物科技有限公司 | Edible compound mitochondrial energy enhancing formula |
| EP4262806A1 (en) * | 2020-12-21 | 2023-10-25 | Oxford University Innovation Limited | Treatment of disorders associated with low bh4 bioavailability |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1582756A (en) * | 2004-05-25 | 2005-02-23 | 武汉福格森保健食品有限公司 | Nutrient capsules for pregnant woman |
-
2015
- 2015-08-13 CN CN201510496987.5A patent/CN105106217B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1582756A (en) * | 2004-05-25 | 2005-02-23 | 武汉福格森保健食品有限公司 | Nutrient capsules for pregnant woman |
Non-Patent Citations (2)
| Title |
|---|
| 孕期补充叶酸：不仅仅是预防神经管缺陷;James A. Greenberg等;《妇产与遗传（电子版）》;20120930;第2卷(第3期);第53-59页 * |
| 左旋精氨酸治疗胎儿宫内生长迟缓的临床观察;郭晓燕 等;《广东医学》;20020831;第23卷(第8期);第864-865页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105106217A (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102318835B (en) | Composition for reducing bone loss and preparation method thereof | |
| US6361800B1 (en) | Multi-vitamin and mineral supplement | |
| Fall | Maternal nutrition: effects on health in the next generation | |
| CN105106217B (en) | A kind of maternal nutritional replenishers and preparation method thereof | |
| CN1400870A (en) | Improved pediatric formula and methods for providing nutrition and improving tolerance | |
| CN101904507B (en) | Ferrous bisglycinate chelate nutritional composition and application thereof | |
| JP2023068107A (en) | Methods and compositions for treating thyroid-related medical conditions with reduced folate | |
| CN104382934A (en) | Multivitamin tablet for pregnant women | |
| JP5419298B2 (en) | Formulation containing calcium, magnesium, zinc and vitamin D3 for prevention and recovery of osteoporosis | |
| CN101176734A (en) | Nutrients replenisher for replenishing folic acid and vitamin B12 and preparation method thereof | |
| CA2505103A1 (en) | Nutritional supplement for adults | |
| CN101279089B (en) | Donkey-hide gelatin calcium composition and preparing process thereof | |
| CN109619308A (en) | It is a kind of for improving cat immunity prevent cat nose nutrition paste formulation and preparation method thereof | |
| KR20080008155A (en) | Nutritional composition comprising vitamins, minerals, or fermented natural substances especially necessary for koreans | |
| CN100360139C (en) | Lead-removing growth-assisting tablet and its preparing method | |
| CN102613543A (en) | Multi-vitamin and multi-mineral soft capsules | |
| CN110292177A (en) | A kind of composition and its preparation method and application promoting children's bone growth and development | |
| CN101129406A (en) | Formula of compound colla carapaeis corii asini series products and method for producing the same | |
| CN1985848B (en) | Compound vitamin and mineral preparation for prenatal taking | |
| CN112869173A (en) | Composite vitamin mineral preparation and preparation method thereof | |
| RU2557527C1 (en) | Method of correction of immunobiochemical status in cows in prenatal and postpartum periods | |
| CN1582756A (en) | Nutrient capsules for pregnant woman | |
| Kristoffersen et al. | Vitamin supplements and intrauterine growth | |
| CN101306015B (en) | Composition for increasing embryo quality and preventing and curing defect baby from generating | |
| US11065271B2 (en) | Maternal vitamin B12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Ping Inventor after: Li Chenxi Inventor after: Wu Sai Inventor before: Li Ping |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170515 Address after: 255000, No. 12, building 701, East Garden, Nanjing Road, Zhangdian District, Shandong, Zibo Applicant after: Li Jian Address before: 255000, No. 12, building 701, East Garden, Nanjing Road, Zhangdian District, Shandong, Zibo Applicant before: ZIBO WEIKEXUN MEDICAL TECHNOLOGY CO., LTD. |
|
| CB03 | Change of inventor or designer information |
Inventor after: Li Ping Inventor after: Li Chenxi Inventor before: Li Ping Inventor before: Li Chenxi Inventor before: Wu Sai |
|
| CB03 | Change of inventor or designer information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Ping Inventor after: Li Chenxi Inventor after: Li Jian Inventor before: Li Ping Inventor before: Li Chenxi |